Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
133.41
-3.71 (-2.71%)
At close: Mar 28, 2025, 4:00 PM
132.01
-1.40 (-1.05%)
Pre-market: Mar 31, 2025, 8:31 AM EDT

Repligen Market Cap

Repligen has a market cap or net worth of $7.49 billion as of March 31, 2025. Its market cap has decreased by -30.91% in one year.

Market Cap
7.49B
Enterprise Value
7.42B
1-Year Change
-30.91%
Ranking
Category
Stock Price
$133.41

Market Cap Chart

Since December 1, 1998, Repligen's market cap has increased from $28.10M to $7.49B, an increase of 26,557.58%. That is a compound annual growth rate of 23.62%.

History

DateMarket Cap% Change
Mar 28, 20257.49B-7.11%
Dec 31, 20248.06B-19.67%
Dec 29, 202310.04B6.78%
Dec 30, 20229.40B-35.80%
Dec 31, 202114.64B45.21%
Dec 31, 202010.08B109.40%
Dec 31, 20194.82B108.18%
Dec 31, 20182.31B46.35%
Dec 29, 20171.58B51.58%
Dec 30, 20161.04B11.88%
Dec 31, 2015932.00M43.85%
Dec 31, 2014647.90M48.87%
Dec 31, 2013435.20M122.72%
Dec 31, 2012195.40M83.30%
Dec 30, 2011106.60M-26.18%
Dec 31, 2010144.40M14.24%
Dec 31, 2009126.40M7.21%
Dec 31, 2008117.90M-41.78%
Dec 31, 2007202.50M137.12%
Dec 29, 200685.40M-29.07%
Dec 30, 2005120.40M39.03%
Dec 31, 200486.60M-33.64%
Dec 31, 2003130.50M57.04%
Dec 31, 200283.10M28.04%
Dec 31, 200164.90M-27.65%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings